The FTC Second Request signals heightened antitrust scrutiny and likely delays the merger close by several months. Monitor for substantial compliance announcements and any FTC action to terminate the waiting period; a longer-than-expected review could increase deal risk or renegotiation risk.
Price Chart
Executive Summary
MiMedx Group disclosed that it and Sanara MedTech each received a Second Request from the FTC on October 15, 2026, in connection with the FTC's review of their pending merger. This extends the HSR Act waiting period until 30 days after substantial compliance with the Second Request, introducing a material delay and uncertainty to deal closing timing.
Key Facts
- MiMedx and Sanara each received a Second Request from the FTC on October 15, 2026.
- The Second Request extends the HSR waiting period until 30 days after the parties have substantially complied.
- Completion of the merger remains subject to expiration or termination of the HSR waiting period and satisfaction of other closing conditions.
- The company states it continues to work constructively with the FTC.
Financial Impact
No specific dollar amounts disclosed; the Second Request introduces a material delay to a merger whose terms were not disclosed in this filing.
Risk Factors
- Extended delay or failure to close due to FTC review; potential for the FTC to seek an injunction to block the merger; deal termination if conditions not met.
- No specific financial figures or deal value disclosed in this filing.
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 8-K Filing (Primary) | 0001213900-26-110041 |
| Document: 0001213900-26-110041-index-headers.html | 0001213900-26-110041 |
| Document: 0001213900-26-110041-index.html | 0001213900-26-110041 |
| Document: 0001213900-26-110041.txt | 0001213900-26-110041 |
Track record builds as more directional reports settle.
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 16, 2026 11d ago | 425 | $4.43 $3.91 | ▼ −11.74% | ▼ −11.83% | $3.90 (−11.96%) |
Oct 16, 2026 11d ago | 8-K | $4.43 $3.91 | ▲ +11.74% | ▲ +11.83% | $3.90 (+11.96%) |
Jun 2, 2026 21w ago | Court Ruling | $3.57 $3.71 | ▲ +3.92% | ▲ +6.89% | $3.90 (+9.24%) |
Apr 29, 2026 25w ago | DEFA14A | $3.36 $3.66 | ▲ +8.93% | ▲ +7.20% | $3.90 (+16.07%) |
Apr 22, 2026 26w ago | Press Release | $3.31 $3.27 | ▼ −1.36% | ▼ −1.41% | $3.90 (+17.82%) |
Apr 16, 2026 27w ago | 8-K | $3.43 $3.35 | ▲ +2.33% | ▲ +3.32% | $3.90 (−13.70%) |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers